Publications

Journal of Clinical Microbiology, 52(5), 1 May 2014, pp 1741-44, doi: 10.1128/JCM.03614-13
Intensive Care Medicine, 40(4), 1 April 2014, pp 564–571, doi: 10.1007/s00134-014-3225-8
Expert Opinion on Therapeutic Targets, 18(8), 1 August 2014, pp 851-61, doi: 10.1517/14728222.2014.925881

Project Partners

R-GNOSIS is coordinated by Marc Bonten (UMC Utrecht) and brings together a multidisciplinary team with complementary expertise of clinicians, microbiologists and epidemiologists, infectious disease specialists, caregivers in inpatient care and mathematical modellers. The R-GNOSIS consortium is made of 19 partners from 9 countries which include United Kingdom, Denmark, Germany, Netherlands, Belgium, France, Spain, Switzerland and Israel.

The Madrid Health Service, SERMAS, ES

The Madrid Health Service, SERMAS, ES


Further Information :

Organizational Activities

The Madrid Health Service / Servicio Madrileño de Salud (SERMAS) is working together with the Foundation for Biomedical Research (Fundación para la Investigación Biomédica en el Hospital Universitario Ramón y Cajal) as a third party. The Ramón y Cajal University Hospital is a 1,300 bed public hospital that belongs to the National Institute of Health of the Madrid’s Community of Spain. The Department of Clinical Microbiology, the operational partner in the project, has a high publication rate (100 impact factor/year during the last 5 years) and is fully equipped with clinical diagnostic duties and molecular microbiology research (19 researchers) and participated in several EU projects (PAR, TROCAR, KBBE, ACE, DRESP, EAR, COBRA, DEAR, EVOTAR, and R-GNOSIS).

Further information:

Hospital Universitario Ramón y Cajal. http://www.hrc.es

Instituto Ramón y Cajal de Investigación Sanitaria. http://www.irycis.org/

Role in the Project

Key Personnel

Rafael Cantón, PhD. Associated Professor and Chief of the Department of Clinical Microbiology, Hospital  Universitario Ramón y Cajal-SERMAS. Research background: genetics, biochemistry, molecular biology including mechanisms of resistance epidemiology and spread of genes and clones. He has published >250 papers in peer-reviewed scientific journals and is associated editor of Clinical Microbiology and Infection. He is currently Chairman of EUCAST (European Committee of Antimicrobial Susceptibility Testing).  - no image description is available -
Fernando Baquero, MD PhD, Senior scientist, Hospital Universitario Ramón y Cajal-SERMAS. Research background: genetics and population biology, evolutionary genetics including resistant pathogens, virulence determinants. He has published >350 papers in scientific journals. Currently he is the scientific director of IRYCIS (Instituto Ramón y Cajal de Investigación Sanitaria) - no image description is available -
Teresa M. Coque, PhD. Senior scientist at FiBIO-IRYCIS, PhD in Molecular Epidemiology and Antibiotic Resistance. Research background: molecular epidemiology, population biology and characterization of integrons, transposons and plasmids. She has published >350 papers in scientific journals. - no image description is available -
Patricia Ruiz-Garbajosa, PhD. Junior scientist at Department of Clinical Microbiology, Hospital Universitario Ramón y Cajal-SERMAS. Research background: genetics, molecular epidemiology of resistant genes and clones. She has published >20 papers in peer-reviewed scientific journals - no image description is available -

Ana Moren-Bofarull.  Project manager. She has participated in the management of several EU projects at Department of Clinical Microbiology, Hospital Universitario Ramón y Cajal-SERMAS, including PAR, TROCAR, ACE, and currently in EVOTAR, and R-GNOSIS.

- no image description is available -